Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Chromatogr B Biomed Sci Appl ; 744(2): 241-7, 2000 Jul 21.
Article in English | MEDLINE | ID: mdl-10993511

ABSTRACT

We report a new high-performance liquid chromatography method developed for measuring inulin in plasma and urine using ion moderated partition chromatography and evaporative light-scattering detection. Samples are deproteinized with a zinc acetate and phosphotungstic acid solution and added with melezitose as an internal standard. The chromatographic separation is carried out in 16 min at a flow-rate of 0.6 ml/min using deionized water as the mobile phase. Within-run precision, measured at four different concentrations (0.050 mg/ml, 0.150 mg/ml, 0.300 mg/ml and 1.200 mg/ml), ranges from 1.7 to 3.4% in plasma and from 1.5 to 3.5% in urine. Similarly, between-run precision is in plasma from 2.0 to 4.3% and in urine from 2.0 to 4.4%. Analytical recovery ranges from 97.9 to 100.1% in plasma and from 99.1 to 99.7% in urine, respectively. Detection limit (signal-to-noise ratio=3) is 5 microg/ml both in plasma and urine. The method is simple, sensitive, without interference due to hexoses or drugs commonly taken by patients with renal diseases, and offers the advantage of measuring inulin without previous hydrolysis of the molecule.


Subject(s)
Chromatography, High Pressure Liquid/methods , Inulin/analysis , Adolescent , Adult , Calibration , Child , Child, Preschool , Female , Humans , Inulin/blood , Inulin/urine , Light , Male , Reproducibility of Results , Scattering, Radiation , Sensitivity and Specificity
2.
Int J Artif Organs ; 16 Suppl 5: 168-72, 1993 Dec.
Article in English | MEDLINE | ID: mdl-7912229

ABSTRACT

Photopheresis (ECP) is a new therapy for oncological and autoimmune diseases consisting in the reinfusion of 3-9 x 10(9) leukocytes, taken from the patient by leukapheresis, and treated in an extracorporeal system with 8-methoxypsoralen and ultraviolet light A. Nine patients affected by T cell immunomediated diseases (2 scleroderma, 1 chronic GVHD, 1 polyarteritis, 1 rheumatoid arthritis and 4 heart transplant patients with numerous episodes of acute rejection) were treated with ECP. Photopheresis was performed on 2 consecutive days every 3-4 weeks. All patients affected by autoimmune diseases experienced an improvement during treatment with ECP. In 2 of the 4 patients with heart transplant, rejection was reversed by photopheresis. No major side effects were observed during the treatment. In conclusion ECP is a safe and well tolerated therapy. Although the number of patients is small, ECP seems to be an effective modality in many diseases.


Subject(s)
Photopheresis , Adolescent , Adult , Arthritis, Rheumatoid/drug therapy , Child , Female , Graft Rejection/drug therapy , Graft vs Host Disease/drug therapy , Heart Transplantation , Humans , Leukapheresis , Male , Middle Aged , Polyarteritis Nodosa/drug therapy , Scleroderma, Systemic/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...